CS logo
small CS logo
Saint Louis University Hospital

Saint Louis, Missouri, United States
Medical center in St. Louis, Missouri
1201 S Grand Blvd, St. Louis, MO 63104
356 Beds

About Saint Louis University Hospital


Saint Louis University Hospital is a 356-bed non-profit, research and academic medical center located in St. Louis, Missouri, providing tertiary care for the east Missouri region. The medical center is a part of the SSM Health System and is affiliated with the Saint Louis University School of Medicine.
There are 356 beds in Saint Louis University Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Saint Louis University Hospital


During the past decade, Saint Louis University Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 62 clinical trials were completed, i.e. on average, 172.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 19 clinical trials were completed. i.e. 316.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33775511114411441199771111661010777733Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
2002-04-01
Completed
500
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
2002-09-01
2004-12-01
Completed
600
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
2005-06-01
Completed
130
Effects of ONO-2506PO in Patients With Alzheimer's Disease
2004-06-01
2007-07-01
Completed
647

Rows per page:

1–100 of 142

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Saint Louis University Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "St. Louis University" with 10 trials sponsored, "Point Biomedical" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 69 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Louis University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 68 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 33National CancerInstitute (NCI): 33St. Louis University: 10St. Louis University: 10Point Biomedical: 5Point Biomedical: 5Boston Scientific Corporation: 4Boston Scientific Corporation: 4Gilead Sciences: 4Gilead Sciences: 4Abbott Medical Devices: 3Abbott Medical Devices: 3Duke University: 3Duke University: 3ECOG-ACRIN CancerResearch Group: 3ECOG-ACRIN CancerResearch Group: 3GOG Foundation: 3GOG Foundation: 3Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 16National CancerInstitute (NCI): 16NRG Oncology: 10NRG Oncology: 10NCIC Clinical Trials Group: 6NCIC Clinical Trials Group: 6Cancer and LeukemiaGroup B: 5Cancer and LeukemiaGroup B: 5National Institute ofNeurological Disordersand Stroke (NINDS): 5National Institute ofNeurological Disordersand Stroke (NINDS): 5SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5Eastern CooperativeOncology Group: 4Eastern CooperativeOncology Group: 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4Medical University ofSouth Carolina: 3Medical University ofSouth Carolina: 3North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3

Clinical Trials Conditions at Saint Louis University Hospital


According to Clinical.Site data, the most researched conditions in "Saint Louis University Hospital" are "Coronary Artery Disease" (9 trials), "Cervical Adenocarcinoma" (4 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (4 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (4 trials). Many other conditions were trialed in "Saint Louis University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Saint Louis University Hospital


Most popular intervention types in "Saint Louis University Hospital" are "Drug" (88 trials), "Other" (40 trials), "Biological" (35 trials), "Device" (17 trials) and "Procedure" (11 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Bevacizumab" (14 trials), "Paclitaxel" (12 trials), "Placebo" (12 trials) and "Quality-of-Life Assessment" (11 trials). Other intervention names were less common.

Clinical Trials Genders at Saint Louis University Hospital


The vast majority of trials in "Saint Louis University Hospital" are 119 trials for "All" genders, 18 trials for "Female" genders and 5 trials for "Male" genders.

Clinical Trials Status at Saint Louis University Hospital


Currently, there are NaN active trials in "Saint Louis University Hospital". undefined are not yet recruiting, 14 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Saint Louis University Hospital, undefined suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Louis University Hospital, 4 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 61Phase 3: 61Phase 2: 39Phase 2: 39Not Applicable: 13Not Applicable: 13Phase 4: 5Phase 4: 5Phase 1: 4Phase 1: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 77Completed: 77Active, not recruiting: 28Active, not recruiting: 28Terminated: 18Terminated: 18Recruiting: 14Recruiting: 14Unknown status: 3Unknown status: 3Withdrawn: 2Withdrawn: 2